Bernstein Maintains Outperform on Guardant Health, Raises Price Target to $200
Bernstein analyst Eve Burstein maintains Guardant Health (NASDAQ: GH ) with a Outperform and raises the price target from $175 to $200.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.